Trials / Unknown
UnknownNCT03025919
Evaluation of Innovated Screening Tools for Type 2 Diabetes Among Chinese Population(SENSIBLE STUDY I)
Using 2h-glycosuria Combined With Fasting Plasma Glucose , Advanced Glycation End-product Alone or in Combination With Fasting Plasma Glucose in Diabetes Screening in Chinese Natural Population
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 20,000 (estimated)
- Sponsor
- Zhongda Hospital · Academic / Other
- Sex
- All
- Age
- 12 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Evaluation of using 2h-UG combined with FPG, AGEsP alone or in combination with FPG in diabetes screening in Chinese natural population
Detailed description
Using the WHO criteria as the golden standard，drawing the ROC curve of 2h-UG combined with FPG, AGEsP alone or in combination with FPG，calculating the area under the ROC curve.
Conditions
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2017-06-01
- Completion
- 2017-12-01
- First posted
- 2017-01-20
- Last updated
- 2017-05-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03025919. Inclusion in this directory is not an endorsement.